MedPath

Tyrothricin

Generic Name
Tyrothricin
Drug Type
Small Molecule
CAS Number
1404-88-2
Unique Ingredient Identifier
877376V2XW

Overview

Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus . This complex is a mixture comprised of 60% tyrocidine cationic cyclic decapeptides (consisting largely of the six predominant tyrocidines, TrcA/A1, TrcB/B1, TrcC/C1, and other more minor contributors) and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary) . Moreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years of therapeutic use the complex has provided . Nevertheless, as tyrothricin is both cytolytic and hemolytic, it does demonstrate systemic toxicity , although certain formulations that are safe for human use like throat lozenges do exist .

Indication

Tyrothricin is used as an over the counter topical antibiotic.

Associated Conditions

  • Bacterial Sinusitis
  • Bacterial rhinitis
  • Gingivitis
  • Inflammation of Mouth
  • Oral bacterial infection
  • Pharyngitis
  • Skin Infections
  • Sore Throat
  • Stomatitis
  • Tonsillar inflammation
  • Tonsillitis
  • Vaginal Infections
  • Vaginitis Trichomonal
  • Oral infections
  • Throat infections
  • Throat inflammation
  • Tongue inflammation
  • Ulceration of the mouth

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
DORITHRICIN THROAT LOZENGES
SIN04392P
LOZENGE
0.5 mg
5/3/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
PULMOSIRUM PASTILLE
nutribon (1986) inc.
01912461
Lozenge - Oral
1.5 MG / LOZ
12/31/1994
ANTIBIOTIC COLD SORE OINTMENT
columbia laboratories canada inc
01910914
Ointment - Topical
0.5 MG / G
12/31/1992
ANTIBIOTIC LOZENGES
nutribon (1986) inc.
02049252
Lozenge - Oral
1.5 MG / LOZ
12/31/1994
EMERCREME NO4 ONT EFA
pharmavite laboratories (1987) inc.
00581771
Ointment - Topical
1 MG / G
12/31/1984
LARYNGETS LOZ
nutribon (1986) inc.
01940775
Lozenge - Buccal
1.5 MG
12/31/1992
SEPTOMIXINE FORTE
00229652
Paste - Dental
1.5 G / 100 G
12/31/1972
GERCILLIN
les produits gerbex inc.
00461172
Lozenge - Oral
1.5 MG / LOZ
12/31/1987
SOROPON SHAMPOO
axxess pharma inc.
00158380
Liquid - Topical
.1 %
12/31/1960

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
BUCOMETASANA COMPRIMIDOS PARA CHUPAR
Cooper Consumer Health B.V.
46669
COMPRIMIDO PARA CHUPAR
Sin Receta
Commercialized
ANGINOVAG SOLUCION PARA PULVERIZACION BUCAL
37453
SOLUCIÓN PARA PULVERIZACIÓN BUCAL
Medicamento Sujeto A Prescripción Médica
Commercialized
COHORTAN RECTAL POMADA
Laboratorio Reig Jofre, S.A.
40353
POMADA RECTAL
Sin Receta
Not Commercialized
CUCODOL 0,5 MG/2 MG/2 MG COMPRIMIDOS PARA CHUPAR
Pharmex Advanced Laboratories S.L.
45613
COMPRIMIDO PARA CHUPAR
Sin Receta
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.